Updates in the Front-Line Management of Metastatic/Unresectable Endometrial Cancer

January 10, 2024

A Zoom Link will be emailed to you the day before the event.

Target Audience

All pharmacists

Learning Objectives

 

At the completion of this activity, the participant will be able to:


Describe the epidemiology, pathophysiology, and diagnostics of endometrial cancer
Identify molecular targets and evaluate literature supporting targeted/immunotherapies in endometrial cancer
Name literature that supports the use of targeted therapies/immunotherapies in the upfront management of endometrial cancer
List drug-specific considerations which may impact patient care

 

 

 

 

 

Course summary
Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
11/27/2023
Course expires: 
11/21/2025
Event starts: 
01/10/2024 - 7:00pm EST
Event ends: 
01/10/2024 - 8:00pm EST
Cost:
$10.00
Add to calendar: 
Rating: 
0
Zoom
NY 12866
United States

 

 

  • o Bianca Bucuresteanu/PGY2 Oncology Pharmacy Resident/PharmD, MHS

    o Dr. Bianca Bucuresteanu is from Springfield, NJ. She received her Doctor of Pharmacy degree at Fairleigh Dickinson University in 2022. She completed her PGY-1 pharmacy residency at Penn Medicine Princeton Medical Center in Plainsboro, NJ. Her professional interests include hematologic malignancies and clinical trial research. Her future goals include practicing at an academic institution and precepting.

    •  

 

ACPE UAN #   0042-0000-23-093-L01-P

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$10.00
Please login or register to take this course.